New treatment options in the management of IBD – focus on colony stimulating factors
Open Access
- 1 September 2008
- journal article
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. 2 (3) , 501-504
- https://doi.org/10.2147/BTT.S3543
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 28 references indexed in Scilit:
- NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytesInflammatory Bowel Diseases, 2008
- Reduced -defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's diseaseGut, 2008
- Innate immunity in inflammatory bowel disease: a disease hypothesisThe Journal of Pathology, 2007
- Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine ReleaseThe Journal of Immunology, 2005
- An open‐labelled study of granulocyte colony‐stimulating factor in the treatment of active Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2005
- NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal -defensin expressionGut, 2004
- Crohn's diseaseEuropean Journal of Gastroenterology & Hepatology, 2003
- Superoxide production by Crohn's disease neutrophils.Gut, 1991
- Complement and function of neutrophils in chronic inflammatory bowel disease.1986
- NEUTROPHIL DYSFUNCTION IN CROHN'S DISEASEThe Lancet, 1976